HLA typing
FDA Approves Thermo Fisher Scientific HLA Typing Kit as CDx for Adaptimmune T-Cell Receptor Therapy
Adaptimmune's therapy is intended to treat patients with unresectable or metastatic synovial sarcoma who have received prior chemotherapy.
GenDx, OSE Immunotherapeutics Ink Deal to Develop NGS CDx for Epitope-Based Cancer Vaccine
Under the deal, GenDx will develop and validate a companion diagnostic test for high-resolution typing of HLA-A*02 based on its IVDR-registered NGS products.
FDA Approves Thermo Fisher HLA Typing Test as CDx for Immunocore Uveal Melanoma Therapy
The marketing authorization makes Thermo Fisher’s SeCore CDx HLA Sequencing System the first and so far only commercially available HLA typing companion diagnostic.
Immucor, Pirche Partner to Embed Epitope Matching Prediction Pipeline into Transplant Dx Software
An unspecified investment will give Immucor exclusive access to PIRCHE scores and embedded visualizations for HLA antibody analysis.
GenDx Gets IVDR Certificate for HLA Typing Products
The regulation establishes, among other things, increased quality management and continuous evaluation for in vitro diagnostics, the company said.